Literature DB >> 7536795

Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins.

J P Lévesque1, D I Leavesley, S Niutta, M Vadas, P J Simmons.   

Abstract

Cytokines are known to be important regulators of normal hemopoiesis, acting in concert with components of the bone marrow microenvironment. Interactions with this microenvironment are known to regulate the proliferation, differentiation, and homing of hemopoietic progenitor (CD34+) cells. Adhesive interactions with the extracellular matrix retain CD34+ cells in close proximity to cytokines, but may also provide important costimulatory signals. Thus, the functional states of adhesion receptors are critical properties of CD34+ cells, but the physiological mechanisms responsible for regulating functional properties of cell adhesion receptors on primitive hemopoietic cells are still unknown. We confirm that the integrins very late antigen (VLA)-4 and VLA-5 are expressed on the CD34+ cell lines MO7e, TF1, and on normal bone marrow CD34+ progenitor cells, but in a low affinity state, conferring on them a weak adhesive phenotype on fibronectin (Fn). Herein, we show that the cytokines interleukin (IL)-3, granulocyte-macrophage CSF (GM-CSF), and KIT ligand (KL) are physiological activators of VLA-4 and VLA-5 expressed by MO7e, TF1, and normal bone marrow CD34+ progenitor cells. Cytokine-stimulated adhesion on Fn is dose dependent and transient, reaching a maximum between 15 and 30 min and returning to basal levels after 2 h. This cytokine-dependent activation is specific for VLA-4 and VLA-5, since activation of other beta 1 integrins was not observed. The addition of second messenger antagonists staurosporine and W7 abolished all cytokine-stimulated adhesion to Fn. In contrast, genistein inhibited KL-stimulated adhesion, but failed to inhibit GM-CSF- and IL-3-stimulated adhesion. Our data suggest that cytokines GM-CSF and IL-3 specifically stimulate beta 1 integrin function via an "inside-out" mechanism involving protein kinase activity, while KL stimulates integrin activity through a similar, but initially distinct, pathway via the KIT tyrosine-kinase. Thus, in addition to promoting the survival, proliferation, and development of hemopoietic progenitors, cytokines also regulate adhesive interactions between progenitor cells and the bone marrow microenvironment by modifying the functional states of specific integrins. These data are of importance in understanding the fundamental processes of beta 1 integrin activation and cellular response to mitogenic cytokines as well as on the clinical setting where cytokines induce therapeutic mobilization of hematopoietic progenitors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7536795      PMCID: PMC2192007          DOI: 10.1084/jem.181.5.1805

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  53 in total

1.  Alpha 4 beta 1 and alpha 5 beta 1 are differentially expressed during myelopoiesis and mediate the adherence of human CD34+ cells to fibronectin in an activation-dependent way.

Authors:  J M Kerst; J B Sanders; I C Slaper-Cortenbach; M C Doorakkers; B Hooibrink; R H van Oers; A E von dem Borne; C E van der Schoot
Journal:  Blood       Date:  1993-01-15       Impact factor: 22.113

Review 2.  Potential adhesion mechanisms for localisation of haemopoietic progenitors to bone marrow stroma.

Authors:  P J Simmons; A Zannettino; S Gronthos; D Leavesley
Journal:  Leuk Lymphoma       Date:  1994-02

Review 3.  Hematopoietic regulators: redundancy or subtlety?

Authors:  D Metcalf
Journal:  Blood       Date:  1993-12-15       Impact factor: 22.113

4.  Hemopoietic stromal microenvironment.

Authors:  M Tavassoli; A Friedenstein
Journal:  Am J Hematol       Date:  1983-09       Impact factor: 10.047

5.  Direct interaction of calmodulin antagonists with Ca2+/calmodulin-dependent cyclic nucleotide phosphodiesterase.

Authors:  H Itoh; H Hidaka
Journal:  J Biochem       Date:  1984-12       Impact factor: 3.387

6.  Forskolin potentiation of cholera toxin-stimulated cyclic AMP accumulation in intact C6-2B cells. Evidence for enhanced Gs-C coupling.

Authors:  K Barovsky; G Brooker
Journal:  Mol Pharmacol       Date:  1985-12       Impact factor: 4.436

7.  Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism.

Authors:  T A Haystead; A T Sim; D Carling; R C Honnor; Y Tsukitani; P Cohen; D G Hardie
Journal:  Nature       Date:  1989-01-05       Impact factor: 49.962

8.  Role of beta 1 and beta 2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma.

Authors:  J Teixidó; M E Hemler; J S Greenberger; P Anklesaria
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

9.  Modulation of the affinity of integrin alpha IIb beta 3 (GPIIb-IIIa) by the cytoplasmic domain of alpha IIb.

Authors:  T E O'Toole; D Mandelman; J Forsyth; S J Shattil; E F Plow; M H Ginsberg
Journal:  Science       Date:  1991-11-08       Impact factor: 47.728

10.  JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region.

Authors:  F W Quelle; N Sato; B A Witthuhn; R C Inhorn; M Eder; A Miyajima; J D Griffin; J N Ihle
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

View more
  41 in total

Review 1.  Regulatory pathways in blood-forming tissue with particular reference to gap junctional communication.

Authors:  M Rosendaal ; T Krenács T
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

2.  Gab1 mediates hepatocyte growth factor-stimulated mitogenicity and morphogenesis in multipotent myeloid cells.

Authors:  Angelina Felici; Alessio Giubellino; Donald P Bottaro
Journal:  J Cell Biochem       Date:  2010-10-01       Impact factor: 4.429

Review 3.  Adhesion receptors involved in HSC and early-B cell interactions with bone marrow microenvironment.

Authors:  Maria De Grandis; Anne-Catherine Lhoumeau; Stéphane J C Mancini; Michel Aurrand-Lions
Journal:  Cell Mol Life Sci       Date:  2016-02       Impact factor: 9.261

4.  Surface-immobilization of adhesion peptides on substrate for ex vivo expansion of cryopreserved umbilical cord blood CD34+ cells.

Authors:  Xue-Song Jiang; Chou Chai; Yue Zhang; Ren-Xi Zhuo; Hai-Quan Mao; Kam W Leong
Journal:  Biomaterials       Date:  2006-01-10       Impact factor: 12.479

5.  Pharmacological inhibition of EGFR signaling enhances G-CSF-induced hematopoietic stem cell mobilization.

Authors:  Marnie A Ryan; Kalpana J Nattamai; Ellen Xing; David Schleimer; Deidre Daria; Amitava Sengupta; Anja Köhler; Wei Liu; Matthias Gunzer; Michael Jansen; Nancy Ratner; Timothy D Le Cras; Amanda Waterstrat; Gary Van Zant; Jose A Cancelas; Yi Zheng; Hartmut Geiger
Journal:  Nat Med       Date:  2010-09-26       Impact factor: 53.440

Review 6.  Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4.

Authors:  M P Rettig; G Ansstas; J F DiPersio
Journal:  Leukemia       Date:  2011-09-02       Impact factor: 11.528

Review 7.  Stem cell homing: rolling, crawling, and nesting.

Authors:  P J Quesenberry; P S Becker
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

8.  Bcr/Abl expression stimulates integrin function in hematopoietic cell lines.

Authors:  G Bazzoni; N Carlesso; J D Griffin; M E Hemler
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

9.  Apoptotic death of hematopoietic tumor cells through potentiated and sustained adhesion to fibronectin via VLA-4.

Authors:  Yohei Saito; Toshiyuki Owaki; Takuya Matsunaga; Mizue Saze; Shogo Miura; Mao Maeda; Mayu Eguchi; Rika Tanaka; Junichi Taira; Hiroaki Kodama; Sumio Goto; Yoshiroh Niitsu; Hiroshi Terada; Fumio Fukai
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

10.  Canonical Wnt pathway signaling suppresses VCAM-1 expression by marrow stromal and hematopoietic cells.

Authors:  Sachin Malhotra; Paul W Kincade
Journal:  Exp Hematol       Date:  2008-10-25       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.